BUPROPION-INDUCE D CLIMBING THROU GH D -1 AND D-2 DOPAMINE RECEPTOR ACTIVATION
Authors
Abstract:
Intraperitoneal (IP) injection of bupropion (3,6, amine (4,16 mg kg•') induced dose-dependent climbing in mice. The climbing response induced by both drugs were decreased in animals pretreated either with the 0-1 antagonist SCH 233<)0 or the 0-2 antagonist sulpiride. The α-adrenoceptor blocker phenoxybenzamine decreased the climbing induced by both bupropion and amphetamine, but the β-adrenergic blocker propranolol and the antimuscarinic agent atropine had no effect. Reserpine pretreatment abolished the climbing induced by bupropion but not that of amphetamine. However, alpha-methyl-ptyrosine combined with reserpine treatment reduced the amphetamine-induced climbing. It is concluded that both bupropion and amphetamine-induced climbing through release of dopamine and subsequent activation of 0-1/0-2 receptors however, the mechanisms by which dopamine is released by these drugs may differ.
similar resources
bupropion-induce d climbing throu gh d -1 and d-2 dopamine receptor activation
intraperitoneal (ip) injection of bupropion (3,6, amine (4,16 mg kg•') induced dose-dependent climbing in mice. the climbing response induced by both drugs were decreased in animals pretreated either with the 0-1 antagonist sch 233<)0 or the 0-2 antagonist sulpiride. the α-adrenoceptor blocker phenoxybenzamine decreased the climbing induced by both bupropion and amphetamine, but the β-adre...
full textDopamine D-1 and D-2 receptor antagonists potentiate analgesic and motor effects of morphine.
To examine the role of dopamine receptor subtypes mediating analgesic and motor responses to opioids, rats were pretreated with either saline or a selective D-1 or D-2 dopamine receptor antagonist 10 min prior to morphine (12 mg/kg IP). Analgesic response latency was determined using the hot plate test (52.5 degrees C and 55 degrees C), and catalepsy was assessed using the abnormal posture test...
full textD 1 and D 2 Dopamine Receptors Form Heterooligomers and Co - internalize Following Selective Activation of Either Receptor φ
full text
D(2), but not D(1) dopamine receptor agonists potentiate cannabinoid-induced sedation in nonhuman primates.
In primates, CB(1) cannabinoid receptor agonists produce sedation and psychomotor slowing, in contrast to behavioral stimulation produced by high doses of dopamine receptor agonists. To investigate whether dopamine agonists attenuate the sedative effects of a cannabinoid agonist in monkeys, we compared the effects of D(1) or D(2) dopamine receptor agonists on spontaneous behavior in three to si...
full textEffects of dopamine D 1 and D 2 receptor antagonists on laryngeal 1 neurophysiology in the rat 2
Effects of dopamine D1 and D2 receptor antagonists on laryngeal 1 neurophysiology in the rat 2 Xin Feng, Victor M. Henriquez, Judith R. Walters, Christy L. Ludlow 3 1 Laryngeal and Speech Section, Medical Neurology Branch, National Institute of 4 Neurological Disorders and Stroke, Building 10, Room 5D38, 10 Center Drive MSC 5 1416, Bethesda, MD 20892-1416, USA 6 2 Neurophysiological Pharmacolog...
full textEffects of dopamine D 1 and D 2 receptor antagonists on laryngeal 1 neurophysiology in the rat
Effects of dopamine D1 and D2 receptor antagonists on laryngeal 1 neurophysiology in the rat 2 Xin Feng, Victor M. Henriquez, Judith R. Walters, Christy L. Ludlow 3 1 Laryngeal and Speech Section, Medical Neurology Branch, National Institute of 4 Neurological Disorders and Stroke, Building 10, Room 5D38, 10 Center Drive MSC 5 1416, Bethesda, MD 20892-1416, USA 6 2 Neurophysiological Pharmacolog...
full textMy Resources
Journal title
volume 6 issue 4
pages 285- 289
publication date 1993-02
By following a journal you will be notified via email when a new issue of this journal is published.
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023